La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Human Health Holdings Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Human Health Holdings ha un patrimonio netto totale di HK$764.6M e un debito totale di HK$33.3M, che porta il suo rapporto debito/patrimonio netto a 4.4%. Le sue attività totali e le sue passività totali sono rispettivamente HK$1.1B e HK$307.4M.

Informazioni chiave

4.4%

Rapporto debito/patrimonio netto

HK$33.28m

Debito

Indice di copertura degli interessi	n/a
Contanti	HK$484.41m
Patrimonio netto	HK$764.57m
Totale passività	HK$307.39m
Totale attività	HK$1.07b

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Sep 13

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Jan 23

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Mar 21

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Nov 26

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

May 31

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Feb 15

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

Dec 25

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( HK$612.7M ) di 1419 superano le sue passività a breve termine ( HK$220.0M ).

Passività a lungo termine: Le attività a breve termine di 1419 ( HK$612.7M ) superano le sue passività a lungo termine ( HK$87.4M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 1419 ha più liquidità del suo debito totale.

Riduzione del debito: Il rapporto debito/patrimonio netto di 1419 è aumentato da 0% a 4.4% negli ultimi 5 anni.

Copertura del debito: Il debito di 1419 è ben coperto dal flusso di cassa operativo ( 517.1% ).

Copertura degli interessi: Dati insufficienti per determinare se i pagamenti degli interessi sul debito di 1419 siano ben coperti dall'EBIT.

Human Health Holdings Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

Recent updates

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Human Health Holdings Limited to Report Q4, 2024 Results on Sep 25, 2024

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2024

First half 2024 earnings released: EPS: HK$0.053 (vs HK$0.71 in 1H 2023)

Human Health Holdings Limited to Report First Half, 2024 Results on Feb 27, 2024

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of HK$0.16 per share at 12% yield

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

New minor risk - Profit margin trend

Human Health Holdings Limited Proposes Final Dividend for the Year Ended June 30, 2023, Payable on 29 December 2023

Human Health Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

Human Health Holdings Limited to Report First Half, 2023 Results on Feb 24, 2023

Investor sentiment improved over the past week

Upcoming dividend of HK$0.30 per share

Less than half of directors are independent

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Investor sentiment improved over the past week

Human Health Holdings Limited to Report Fiscal Year 2022 Results on Sep 29, 2022

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Human Health Holdings Limited to Report First Half, 2022 Results on Feb 25, 2022

Human Health Holdings Limited Provides Unaudited Financial Guidance for the Six Months Ended December 31, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.12 per share

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

First half 2021 earnings released: EPS HK$0.045 (vs HK$0.008 in 1H 2020)

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Human Health Holdings Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: HK$0.68

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

New 90-day low: HK$0.55

New 90-day low: HK$0.58

New 90-day low: HK$0.60

Human Health Holdings Limited Resolves Not to Declare Any Final Dividend for Financial Year 2020

Full year earnings released - HK$0.11 loss per share

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane